Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Total Non-Current Liabilities (2020 - 2025)

Cellebrite DI (CLBT) has 6 years of Total Non-Current Liabilities data on record, last reported at $84.9 million in Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities rose 43.75% year-over-year to $84.9 million; the TTM value through Dec 2025 reached $84.9 million, up 43.75%, while the annual FY2025 figure was $84.9 million, 43.75% up from the prior year.
  • Total Non-Current Liabilities reached $84.9 million in Q4 2025 per CLBT's latest filing, up from $59.0 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $244.8 million in Q4 2023 and bottomed at $59.0 million in Q4 2024.
  • Average Total Non-Current Liabilities over 5 years is $147.4 million, with a median of $121.7 million recorded in 2022.
  • Peak YoY movement for Total Non-Current Liabilities: skyrocketed 466.45% in 2021, then tumbled 75.89% in 2024.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $226.6 million in 2021, then tumbled by 46.3% to $121.7 million in 2022, then skyrocketed by 101.27% to $244.8 million in 2023, then crashed by 75.89% to $59.0 million in 2024, then soared by 43.75% to $84.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Non-Current Liabilities were $84.9 million in Q4 2025, $59.0 million in Q4 2024, and $244.8 million in Q4 2023.